micro-community-banner
Profile Image
  • Saved

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US - PubMed

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34132735/

Of patients with ASCVD, most with suboptimal LDL-C levels at baseline, only 17.1% had LLT intensification after 2 years, and two-thirds remained at an LDL-C level greater than 70 mg/dL....

Profile Image
  • 4yr
    Guidelines for patients with atherosclerotic cardiovascular disease (ASCVD) recommend intensive statin therapy and adding nonstatin therapy if low-density lipoprotein cholesterol (LDL-C) levels are 70 mg/dL or more. Compliance with guidelines Show More
  • Saved

Who sponsors this service?

Profile Image
  • 4yr
    Hi there! That's a great question. Pharmaceutical manufacturers occasionally sponsor content within our communities. This allows us to provide membership free of charge, and our privacy policy safeguards your personally Show More
  • Saved

Elevated Apolipoprotein A1 and HDL Cholesterol Associated with Age-related Macular Degeneration: 2 Population Cohorts - PubMed

Elevated Apolipoprotein A1 and HDL Cholesterol Associated with Age-related Macular Degeneration: 2 Population Cohorts - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33596319/

1 Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen,Denmark. 2 The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev,Denmark. 3 Department of Clinical Medicine, Faculty...

Profile Image
  • Saved

MiR-145-5p modulates lipid metabolism and M2 macrophage polarization by targeting PAK7 and regulating β-catenin signaling in hyperlipidemia

MiR-145-5p modulates lipid metabolism and M2 macrophage polarization by targeting PAK7 and regulating β-catenin signaling in hyperlipidemia

Source : https://cdnsciencepub.com/doi/abs/10.1139/cjpp-2020-0539

Canadian Journal of Physiology and Pharmacology The present study aims to explore the role of microRNA 145-5p (miR-145-5p) in hyperlipidemia. Using bioinformatics tools and a wide range of function and...

Profile Image
  • Saved

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Source : https://lipidworld.biomedcentral.com/articles/10.1186/s12944-020-01406-4

Background Reduction in elevated serum cholesterol concentrations is important in the management of individuals at risk of atherosclerotic cardiovascular disease (ASCVD), such as myocardial infarction and thrombotic stroke. Although HMGCoA...

Profile Image